Potentiation of Glucocorticoid Activity in Hypoxia through Induction of the Glucocorticoid Receptor
Open accessAbstract
Tissue hypoxia is intimately associated with chronic inflammatory disease and may signal to the resolution of inflammatory processes. Glucocorticoid signaling through the glucocorticoid receptor (GR) represents a clinically important endogenous anti-inflammatory pathway. Microarray analysis reveals that the GR is transcriptionally up-regulated by hypoxia in human renal proximal tubular epithelial cells. Hypoxic up-regulation of the GR was confirmed at the level of promoter activity, mRNA, and protein expression. Furthermore, functional potentiation of glucocorticoid activity in hypoxia was observed as an enhancement of dexamethasone-induced glucocorticoid response element promoter activity and enhanced dexamethasone-mediated inhibition of IL-1β-stimulated IL-8 expression and hypoxia-induced vascular endothelial growth factor expression. Knockdown of enhanced GR gene expression in hypoxia using specific GR small inhibitory RNA (siRNA) resulted in an attenuation of the enhanced glucocorticoid sensitivity. A role for the hypoxia-inducible transcription factor, HIF-1α, in the regulation of GR expression and the associated potentiation of glucocorticoid activity in hypoxia was also demonstrated. These results reveal a novel signaling aspect responsible for the incorporation of hypoxic and glucocorticoid stimuli, which we hypothesize to be an important co-operative pathway for the control of gene expression observed in complex tissue microenvironments in inflamed states.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The IC50-DEX-hypoxanthine correlation indicates an association of immune GR sensitivity with hypoxia.
“Moreover, IC50-DEX showed a significant correlation with hypoxanthine indicating an association of immune GR sensitivity with hypoxia (40).”
From Mechanistic inferences on metabolic dysfunction in posttraumatic stress disorder from an integrated model and multiomic analysis: role of glucocorticoid receptor sensitivity (2019) · cites this paper as [40]
The section “Hypoxia causes a potentiation of glucocorticoid-dependent activity” reports a lower dexamethasone IC50 after hypoxia exposure (0.4 nM versus 7.5 nM in normoxia), supporting a link between hypoxia and glucocorticoid sensitivity. It does not report a correlation between IC50-DEX and hypoxanthine, so the specific basis the citing sentence gives for that link is unsupported. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591 · see citing works
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536 · see citing works
Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
Bamberger, C. M., Schulte, H. M., & Chrousos, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 892 · see citing works
HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney
Ryan, M. J., Johnson, G., KIRK, J. M. W., Fuerstenberg, S. M., Zager, R. A., & Torok‐Storb, B. (1994) · Kidney International · doi:10.1038/ki.1994.6 · Cited by 891 · see citing works
Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
Hagen, T., Taylor, C. T., Lam, F., & Moncada, S. (2003) · Science · doi:10.1126/science.1088805 · Cited by 704 · see citing works
Self-citationMolecular mechanisms of glucocorticoid action: what is important?
Newton, R. C. (2000) · Thorax · doi:10.1136/thorax.55.7.603 · Cited by 507 · see citing works
Nauck, M., Karakiulakis, G., Perruchoud, A. P., Papakonstantinou, E., & Roth, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01464-7 · Cited by 476 · see citing works
Mukaida, N., Morita, M., Ishikawa, Y., Rice, N. R., Okamoto, S., Kasahara, T., & Matsushima, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36831-x · Cited by 425 · see citing works
Molecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 417 · see citing works
The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease
Giaccia, A. J., Simon, M. C., & Johnson, R. (2004) · Genes & Development · doi:10.1101/gad.1243304 · Cited by 380 · see citing works
Intracellular Receptor Concentration Limits Glucocorticoid-Dependent Enhancer Activity*
Vanderbilt, J. N., Miesfeld, R. L., Maler, B. A., & Yamamoto, K. R. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-1-68 · Cited by 349 · see citing works
Hypoxia-inducible Factor and Its Biomedical Relevance
Huang, E. L., & Bunn, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r200030200 · Cited by 313 · see citing works
The glucocorticoid receptor is required for stress erythropoiesisPreprint
Bauer, A., Tronche, F., Wessely, O., Kellendonk, C., Reichardt, H. M., Steinlein, P., Schütz, G., & Beug, H. (1999) · Genes & Development · doi:10.1101/gad.13.22.2996 · Cited by 291 · see citing works
Lindern, M. V., Zauner, W., Mellitzer, G., Steinlein, P., Fritsch, G., Huber, K. R., Löwenberg, B., & Beug, H. (1999) · Blood · doi:10.1182/blood.v94.2.550 · Cited by 248 · see citing works
Limbourg, F. P., Huang, Z., Plumier, J.-C., Simoncini, T., Fujioka, M., Tuckermann, J. P., Schütz, G., Moskowitz, M. A., & Liao, J. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15481 · Cited by 217 · see citing works
Comerford, K. M., Leonard, M. O., Karhausen, J., Carey, R., Colgan, S. P., & Taylor, C. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337412100 · Cited by 185 · see citing works
Self-citationCorticosteroid-insensitive asthma: molecular mechanisms
Adcock, I. M., & Lane, S. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780347 · Cited by 179 · see citing works
Ab, D., & Dunnick, N. R. (1991) · PubMed · Cited by 163 · see citing works
Modulation of glucocorticoid receptor function by protein kinase A.
Rangarajan, P. N., Umesono, K., & Evans, R. M. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.9.1435789 · Cited by 159 · see citing works
Diederich, S., Eigendorff, E., Burkhardt, P., Quinkler, M., Bumke-Vogt, C., Rochel, M., Seidelmann, D., Esperling, P., Oelkers, W., & Bähr, V. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020970 · Cited by 154 · see citing works
Mechanisms of Glucocorticoid-receptor-mediated Repression of Gene Expression
Webster, J. C., & Cidlowski, J. A. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00186-1 · Cited by 152 · see citing works
Leonard, M. O., Cottell, D. C., Godson, C., Brady, H. R., & Taylor, C. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302560200 · Cited by 151 · see citing works
Self-citationSilva, C. M., Powell-Oliver, F. E., Jewell, C. M., Sar, M., Allgood, V., & Cidlowski, J. A. (1994) · Steroids · doi:10.1016/0039-128x(94)90013-2 · Cited by 128 · see citing works
Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases
Sandeep, T. C., & Walker, B. R. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00499-4 · Cited by 120 · see citing works
Role of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression
Kodama, T., Shimizu, N., Yoshikawa, N., Makino, Y., Ouchida, R., Okamoto, K., Hisada, T., Nakamura, H., Morimoto, C., & Tanaka, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302581200 · Cited by 113 · see citing works
Zong, J., Ashraf, J., & Thompson, E. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5580 · Cited by 102 · see citing works
Taylor, C. T., Fueki, N., Agah, A., Hershberg, R. M., & Colgan, S. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19447 · Cited by 86 · see citing works
Self-citationCharacterization of the Human Glucocorticoid Receptor Promoter
Nobukuni, Y., Smith, C. L., Hager, G. L., & Detera‐Wadleigh, S. D. (1995) · Biochemistry · doi:10.1021/bi00025a028 · Cited by 78 · see citing works
Lipoxins Inhibit Akt/PKB Activation and Cell Cycle Progression in Human Mesangial Cells
Mitchell, D., Rodgers, K., Hanly, J. A., McMahon, B. A., Brady, H. R., Martin, F., & Godson, C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63181-1 · Cited by 73 · see citing works
Self-citationIn vivo electron paramagnetic resonance oximetry with particulate materials
Dunn, J. F., & Swartz, H. M. (2003) · Methods · doi:10.1016/s1046-2023(03)00077-x · Cited by 69 · see citing works
Breslin, M. B., & Vedeckis, W. V. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00138-1 · Cited by 65 · see citing works
Newton, T. R., Patel, N. M., Bhat‐Nakshatri, P., Stauss, C. R., Goulet, R. J., & Nakshatri, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18827 · Cited by 64 · see citing works
Hypoxia causes down‐regulation of 11β‐hydroxysteroid dehydrogenase type 2 by induction of Egr‐1
Heiniger, C. D., Kostadinova, R. M., Rochat, M. K., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-0582fje · Cited by 60 · see citing works
Gille, J., Reisinger, K., Westphal-Varghese, B., & Kaufmann, R. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01573.x · Cited by 56 · see citing works
Characterization of promoter 1B in the human glucocorticoid receptor gene
Nunez, B. S., & Vedeckis, W. V. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00676-1 · Cited by 56 · see citing works
Glanemann, M., Strenziok, R., Kuntze, R., et al. (2004) · Surgery · doi:10.1016/j.surg.2003.08.011 · Cited by 53 · see citing works
Nikolaus, S., Fölscn, U., & Schreiber, S. (2000) · PubMed · Cited by 53 · see citing works
Glucocorticoids as prophylaxis against acute mountain sickness
Basu, M., Sawhney, R. C., Kumar, S., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01664.x · Cited by 50 · see citing works
Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis
Neeck, G., Renkawitz, R., & Eggert, M. (2002) · Cytokines Cellular & Molecular Therapy · doi:10.1080/13684730412331302081 · Cited by 45 · see citing works
Therapeutic Targets for Hypoxia-Elicited Pathways
Taylor, C. T., & Colgan, S. P. (1999) · Pharmaceutical Research · doi:10.1023/a:1011936016833 · Cited by 44 · see citing works
Self-citationKanelakis, K. C., Shewach, D. S., & Pratt, W. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204164200 · Cited by 38 · see citing works
A QUEST FOR ERYTHROPOIETIN OVER NINE DECADES
Fisher, J. W. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.1 · Cited by 31 · see citing works
Lindern, M. V., Zauner, W., Mellitzer, G., et al. (1999) · Blood · doi:10.1182/blood.v94.2.550.414k39_550_559 · Cited by 29 · see citing works
Pépin, M.-C., & Barden, N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1647-1653.1991 · Cited by 27 · see citing works
Kanelakis, K. C., & Pratt, W. B. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)64010-3 · Cited by 25 · see citing works
Warriar, N., Pagé, N., & Govindan, M. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18662 · Cited by 24 · see citing works
Zong, J., Ashraf, J., & Thompson, E. B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5580-5585.1990 · Cited by 21 · see citing works
Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-κB and AP-1
Tago, K., Tsukahara, F., Naruse, M., Yoshioka, T., & Takano, K. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.07.056 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Role of the hypothalamic–pituitary–adrenal axis in developmental programming of health and disease
Xiong, F., & Zhang, L. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.11.002 · Cited by 177 · see citing works
Adrenal insufficiency in critical illness
Cooper, M. S., & Stewart, P. M. (2007) · Journal of Intensive Care Medicine · doi:10.1177/0885066607307832 · Cited by 97 · see citing works
Somvanshi, P. R., Mellon, S. H., Flory, J. D., Abu-Amara, D., PTSD Systems Biology Consortium;, Wolkowitz, O. M., Yehuda, R., Jett, M., Hood, L., Marmar, C., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00065.2019 · Cited by 40 · see citing works
- Authors
- Leonard, M. O., Godson, C., Brady, H. R., & Taylor, C. T.
- Affiliations
- University College Dublin (IE)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-02
- Volume
- 174
- Issue
- 4
- Pages
- 2250-2257
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1674797587
- Semantic Scholar
- 8ce4d2e52c67aecd5a1a6dc3476b70445227e4ea
- Cited by
- 100
- References
- 48
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 8 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 6 · 2016: 5 · 2015: 3 · 2014: 5 · 2013: 9 · 2012: 4
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Health Research Board
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoid receptor, tissue hypoxia, HIF-1α, renal proximal tubular epithelial cells, anti-inflammatory signaling, IL-8 expression, vascular endothelial growth factor, siRNA knockdown, chronic inflammation, gene expression regulation
- MeSH terms
- Cell Line, Dexamethasone, DNA-Binding Proteins, Glucocorticoids, Humans, Nuclear Proteins, Promoter Regions, Genetic, Protein Binding, Receptors, Glucocorticoid, Transcription Factors, Transfection, Signal Transduction, Cell Hypoxia, Up-Regulation, Inflammation Mediators, Response Elements, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review